James Cheo

Japan emerges as a compelling opportunity for diversification, boasting a well-diversified stock market and low correlations to other asset classes.

Allure of diversification via Asia-Pacific exposure

2024-06-17T09:12:58.000Z
An injection pen of Zepbound, Eli Lilly’s weight-loss drug. Obesity drugs are expected to be a game changer in healthcare in 2024.

10 themes for 2024: Opportunities in a complex world

2024-01-15T09:00:06.000Z
Travel, airlines and hospitality are among the sectors expected to recover following the easing of zero-Covid measures in China.

Investment trends for 2023

2023-01-30T04:18:46.000Z